SolasCure Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 16

SolasCure General Information

Description

Developer of a wound care therapy designed to treat chronic wounds and support faster healing. The company offers biologic wound gel with continuous debridement and tissue repair activation features, enabling healthcare providers and patients to improve wound management and recovery outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wellington House
  • East Road
  • Cambridge CB1 1BH
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Wellington House
  • East Road
  • Cambridge CB1 1BH
  • England, United Kingdom
+44 01223

SolasCure Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SolasCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Apr-2025 Completed Clinical Trials - Phase 2
6. Accelerator/Incubator 03-Jun-2024 Completed Clinical Trials - Phase 2
5. Grant 20-Mar-2024 Completed Clinical Trials - Phase 2
4. Grant 21-Jun-2023 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B) 27-Mar-2023 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 31-Jan-2021 $21M $21M Completed Clinical Trials - Phase 2
1. Early Stage VC 01-Jan-2018 Completed Startup
To view SolasCure’s complete valuation and funding history, request access »

SolasCure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
A Ordinary
A Ordinary 257,445,314 $0.013639 $0.03 $0.03 1x $0.03 11.82%
Preference 278,246,000 $0.013639 $0.03 $0.03 1x $0.03 12.77%
To view SolasCure’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SolasCure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a wound care therapy designed to treat chronic wounds and support faster healing. The company offers biolog
Drug Discovery
Cambridge, United Kingdom
11 As of 2026

London, United Kingdom
 

Yavne, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SolasCure Competitors (3)

One of SolasCure’s 3 competitors is Biotherapy Services, a Private Equity-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biotherapy Services Private Equity-Backed London, United Kingdom
MediWound Formerly PE-Backed Yavne, Israel
Smith & Nephew (medical devices) Corporation
You’re viewing 3 of 3 competitors. Get the full list »

SolasCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SolasCure Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Texas Medical Center Venture Capital Minority
Innovate UK Government
European Innovation Council Accelerator/Incubator Minority
Meltwind Advisory Venture Capital Minority
Wealth Club Corporation Minority
You’re viewing 5 of 16 investors. Get the full list »

SolasCure FAQs

  • When was SolasCure founded?

    SolasCure was founded in 2017.

  • Where is SolasCure headquartered?

    SolasCure is headquartered in Cambridge, United Kingdom.

  • What is the size of SolasCure?

    SolasCure has 11 total employees.

  • What industry is SolasCure in?

    SolasCure’s primary industry is Drug Discovery.

  • Is SolasCure a private or public company?

    SolasCure is a Private company.

  • What is SolasCure’s current revenue?

    The current revenue for SolasCure is .

  • How much funding has SolasCure raised over time?

    SolasCure has raised $34.2M.

  • Who are SolasCure’s investors?

    Texas Medical Center, Innovate UK, European Innovation Council, Meltwind Advisory, and Wealth Club are 5 of 16 investors who have invested in SolasCure.

  • Who are SolasCure’s competitors?

    Biotherapy Services, MediWound, and Smith & Nephew (medical devices) are competitors of SolasCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process